Washington: US Biotech Company Moderna announced on Wednesday that he had started a clinical test of a vaccine booster dose specifically designed to combat the Omicron variant of Covid-19.
The trial will involve a total of 600 adults – half of whom has received two doses of modernum vaccines at least six months ago, and half have received two doses plus a booster dose that was previously passed.
Booster which specifically targets Omicron will be evaluated as the third and fourth dose.
Moderna started the omicron special vaccine amplifier court
